500672 — Novartis India Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedSmall CapHigh Flyer

Annual income statement for Novartis India, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	3,814	3,999	3,787	3,351	3,563
Cost of Revenue
Gross Profit	2,317	2,184	1,741	1,327	1,535
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	3,666	4,319	3,187	2,722	2,670
Operating Profit	148	-320	601	629	892
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	400	-38.2	1,154	1,228	1,304
Provision for Income Taxes
Net Income After Taxes	209	-37.2	1,034	852	1,009
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	209	-37.2	1,034	852	1,009
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	209	-37.2	1,034	852	1,009
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	7.5	11.6	40.8	32.8	40.9
Dividends per Share
Special Dividends per Share